Pacific Edge Ltd

PEB

Company Profile

  • Business description

    Pacific Edge Ltd is a NewZealand based company involved in developing and commercializing diagnostic and prognostic tools for the early detection and management of cancers. It manages and operates the laboratories used for the detection of bladder cancer. The company operates in two segments: Commercial, which includes sales, marketing, laboratory, and support operations to run the commercial businesses world wide; and Research, which is into research and development of diagnostic and prognostic products for human cancer. The commercial segment contributes to the majority of the revenue. Pacific Edge has a product in the marketplace called Cxbladder. Its geographical segments are the United States, New Zealand, and the Rest of the World.

  • Contact

    87 Saint David Street
    P.O. Box 56
    DunedinSTL9016
    NZL

    T: +64 35776733

    https://www.pacificedgedx.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 March 2027

    Employees

    34

Stocks News & Analysis

stocks

Chart of the Week: Has gold reached bear market territory?

Investors are facing a shifting landscape.
stocks

ASX share benefiting from favourable industry trends

We anticipate further earnings growth.
stocks

Fair value upgrade for this ASX income player

Headwinds in listed energy stocks likely to have passed

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,859.4033.700.38%
CAC 407,816.9444.490.57%
DAX 4022,680.04117.160.52%
Dow JONES (US)46,341.511,125.372.49%
FTSE 10010,176.4548.490.48%
HKSE25,276.65488.511.97%
NASDAQ21,590.63795.993.83%
Nikkei 22553,385.512,321.794.55%
NZX 50 Index12,825.8786.24-0.67%
S&P 5006,528.52184.802.91%
S&P/ASX 2008,646.3027.600.32%
SSE Composite Index3,944.8052.941.36%

Market Movers